EQL Pharma AB (publ) announced that the pharmaceutical Colecalciferol EQL Pharma tablets 800IU and 2000IU has been approved by the Irish Medicines Agency (HPRA) for sale. Approvals are also expected soon from the Netherlands, Norway and Sweden. Colecalciferol EQL Pharma is a prescription drug that contains Vitamin D3, which helps with the uptake and storage of calcium in the skeleton. It is often given as a preventive treatment for osteoporosis. Colecalciferol EQL Pharma will be launched in Sweden during the company's fourth financial quarter.